SCHEMBL2382818

SCHEMBL2382818

C=CC[C@H](COS(C)(=O)=O)[C@@H]1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2382821 1.00 — —
SCHEMBL2382824 1.00 — —
SCHEMBL23670622 0.80 — —
SCHEMBL19285277 0.80 — —
SCHEMBL19285278 0.80 — —
SCHEMBL2386379 0.78 USP2 (0.34) —
SCHEMBL2386378 0.78 USP2 (0.34) —
SCHEMBL2386382 0.78 USP2 (0.34) —
SCHEMBL2385387 0.78 DHODH (0.36) —
SCHEMBL2385397 0.78 DHODH (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293715-B2 10a-Azalide compound crosslinked at 10a- and 12-positions TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-10-23 — — US disclosed
US-20110237784-A1 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-09-29 — — US disclosed
EP-2177526-A1 10A-AZALIDE COMPOUND CROSSLINKED AT POSITION-10A AND POSITION-12 Taisho Pharmaceutical Co. Ltd. (JP) 2010-04-21 — — EP disclosed
Send feedback